BioCentury
ARTICLE | Financial News

Prexton Therapeutics completes venture financing

August 6, 2012 7:00 AM UTC

Prexton Therapeutics S.A., Geneva, Switzerland Business: Neurology Date completed: 7/30/12 Type: Venture financing Raised: €2.1 million ($2.6 million) Investor: Merck Serono ...